Diagnostic Characterization and Evolution of "Triple Negative" Thrombocytosis (CASTETTE)

Regional University Hospital Center (CHRU)

Status: Active, not recruiting

Conditions: Myeloproliferative Neoplasm

Study type: Observational

Funder types: Other

Identifiers

NCT06481332

29BRC24.0135 - CASTETTE

Details and patient eligibility

About

Evaluation of Event free survival in patients with triple-negative thrombocytosis

Full description

Patients with non-reactive thrombocytosis, explored at least by bone marrow biopsy and NGS panel will be included. Clinical and biological characteristics as well as evolution will be recorded retrospectively.

Enrollment: 300 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients with non reactive thrombocytosis for at least 6 months
• availability of bone marrow biopsy and NGS panel

Exclusion criteria

• Unable to consent